Skip to main content

Table 4 Predictors of TLF at 3 years follow-up

From: Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry

Predictors

Univariate

Multivariate

HR (95% CI)

p value

HR (95% CI)

p value

Age

1.04 (1.02–1.06)

 < 0.01

1.03 (1.01–1.05)

0.003

DM

1.79 (1.30–2.47)

 < 0.01

1.78 (1.20–2.56)

0.003

AMI

1.46 (1.08–1.97)

0.015

1.47 (1.02–2.12)

0.038

Chronic renal failure

2.93 (1.21–7.15)

0.018

2.80 (1.12–7.01)

0.028

LVEF < 40%

3.70 (2.32–5.92)

 < 0.01

3.02 (1.88–4.87)

 < 0.01

ISR

2.48 (1.22–5.05)

0.012

2.32 (1.12–4.81)

0.024

CTO

1.74 (1.22–2.47)

 < 0.01

1.53 (1.003–2.33)

0.048

  1. AMI acute myocardial infarction, CTO chronic total occlusion, DM diabetes mellitus, ISR n-stent restenosis, LVEF left ventricular ejection fraction